WuXi Biologics (Cayman) Inc.

OTCPK:WXIB.F Stock Report

Market Cap: US$7.6b

WuXi Biologics (Cayman) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:WXIB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Jun 24BuyUS$2,141,838Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,445,000US$1.48
21 Jun 24BuyUS$1,490,938Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,000,000US$1.49
20 Jun 24BuyUS$305,413Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany200,000US$1.53
12 Jun 24SellUS$140,672Weichang ZhouIndividual95,919US$1.47
12 Jun 24SellUS$850,918Zhisheng ChenIndividual580,209US$1.47
16 May 24SellUS$82,267,702JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany44,283,850US$1.86
13 May 24BuyUS$63,359,908JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany34,381,199US$1.84
28 Mar 24BuyUS$1,473,873Wuxi Biologics Holdings LimitedCompany831,000US$1.77
27 Mar 24BuyUS$432JP Morgan Asset ManagementCompany247US$1.75
27 Mar 24BuyUS$28,860JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany16,500US$1.75
27 Mar 24BuyUS$5,949,815JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,401,667US$1.75
27 Mar 24SellUS$15,562JP Morgan Asset ManagementCompany8,897US$1.75
27 Mar 24SellUS$6,122JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,500US$1.75
26 Mar 24SellUS$9,526,820JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,465,114US$1.74
19 Mar 24SellUS$31,507,098JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,602,783US$1.79
15 Mar 24BuyUS$41,368,375JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany21,989,717US$1.88
08 Mar 24BuyUS$1,864,833JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany831,114US$2.24
08 Mar 24SellUS$43,828JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany19,533US$2.24
08 Mar 24SellUS$12,925,306JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,760,518US$2.24
06 Mar 24SellUS$32,079,959JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,851,005US$2.71
04 Mar 24BuyUS$332J.P. Morgan Private Wealth Advisors LLCCompany126US$2.63
04 Mar 24BuyUS$36,836JP Morgan Asset ManagementCompany14,000US$2.63
04 Mar 24BuyUS$71,042JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany27,000US$2.63
04 Mar 24BuyUS$46,387,990JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,630,196US$2.63
04 Mar 24SellUS$38,152JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany14,500US$2.63
01 Mar 24SellUS$9,929,222JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,124,046US$2.41
28 Feb 24BuyUS$13,366,932JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,541,524US$2.41
26 Feb 24SellUS$45,012,656JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany18,636,736US$2.42
02 Feb 24BuyUS$94,296,631JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany41,742,218US$2.26
26 Jan 24BuyUS$41,389,023BlackRock, Inc.Company10,996,500US$3.76
24 Jan 24BuyUS$19,227,201Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany5,235,500US$3.67
23 Jan 24SellUS$20,382,963BlackRock, Inc.Company5,595,500US$3.64
17 Jan 24BuyUS$387,276Kenneth Walton HitchnerIndividual100,000US$3.87
17 Jan 24BuyUS$99,672Jackson TaiIndividual25,700US$3.88
28 Dec 23SellUS$36,150,029JP Morgan Asset ManagementCompany9,870,129US$3.66
07 Dec 23SellUS$16,318,436JP Morgan Asset ManagementCompany4,309,654US$3.79
04 Dec 23BuyUS$62,552,361JP Morgan Asset ManagementCompany14,107,685US$4.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of WXIB.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders15,291,2230.373%
Private Companies584,191,13314.2%
Institutions1,420,446,42434.6%
General Public2,084,665,13550.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
Wuxi Biologics Holdings Limited
584,191,133US$1.1b0%no data
4.47%
BlackRock, Inc.
183,303,279US$339.1m0.59%0.01%
3.41%
The Vanguard Group, Inc.
139,772,826US$258.6m-2.88%no data
2.22%
Baillie Gifford & Co.
91,086,386US$168.5m0%0.08%
1.64%
Norges Bank Investment Management
67,514,160US$124.9m0%0.01%
1.5%
Bosera Asset Management Co., Ltd.
61,567,500US$113.9m0%0.51%
1.36%
State Street Global Advisors, Inc.
56,000,760US$103.6m0.34%no data
1.36%
GF Fund Management Co., Ltd.
55,921,000US$103.4m0%0.22%
1.31%
JP Morgan Asset Management
53,690,945US$99.3m0%0.01%
1.22%
JPMorgan Chase & Co, Brokerage and Securities Investments
50,063,659US$92.6m0%0.04%
0.98%
Dimensional Fund Advisors LP
40,166,176US$74.3m-0.43%0.01%
0.79%
China Asset Management Co. Ltd.
32,498,754US$60.1m-0.41%0.07%
0.77%
Zhong Ou Fund Management Co., Ltd
31,689,669US$58.6m0%0.23%
0.76%
Schroder Investment Management (Hong Kong) Ltd.
31,029,500US$57.4m0%0.31%
0.75%
China Merchants Fund Management Company Ltd.
30,742,086US$56.9m0%0.25%
0.71%
UBS Asset Management AG
29,005,811US$53.7m14.4%0.01%
0.54%
Franklin Resources, Inc.
22,250,127US$41.2m0.54%0.01%
0.53%
Hongde Fund Management Co., Ltd.
21,860,649US$40.4m0%0.95%
0.48%
Harvest Fund Management Co. Ltd.
19,505,000US$36.1m0%0.08%
0.43%
Geode Capital Management, LLC
17,581,053US$32.5m1.2%no data
0.35%
Zhisheng Chen
14,486,273US$26.8m1.65%no data
0.34%
Amundi Asset Management SAS
13,907,445US$25.7m2.06%0.01%
0.33%
Hang Seng Investment Management Limited
13,455,755US$24.9m0%0.26%
0.31%
Invesco Great Wall Fund Management Co. Ltd
12,581,918US$23.3m0%0.11%
0.3%
China Asset Management (Hong Kong) Limited
12,109,340US$22.4m6.92%0.78%